Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR.

Nature. 2000 Jul 6;406(6791):86-90.

PMID:
10894547
2.

Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.

Schwabe RF, Brenner DA.

Am J Physiol Gastrointest Liver Physiol. 2002 Jul;283(1):G204-11.

3.

Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.

Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.

Oncogene. 2007 Feb 22;26(8):1201-12. Epub 2006 Aug 21.

PMID:
16924232
4.
5.

NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.

Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA.

Gastroenterology. 2001 Apr;120(5):1251-62.

PMID:
11266388
6.

beta-Catenin activity negatively regulates bacteria-induced inflammation.

Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, Sun J.

Lab Invest. 2007 Jun;87(6):613-24. Epub 2007 Mar 26.

7.

Wnt-1 dependent activation of the survival factor NF-kappaB in PC12 cells.

Bournat JC, Brown AM, Soler AP.

J Neurosci Res. 2000 Jul 1;61(1):21-32.

PMID:
10861796
8.

Oscillating fluid flow inhibits TNF-alpha -induced NF-kappa B activation via an Ikappa B kinase pathway in osteoblast-like UMR106 cells.

Kurokouchi K, Jacobs CR, Donahue HJ.

J Biol Chem. 2001 Apr 20;276(16):13499-504. Epub 2000 Nov 28.

9.

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.

Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC.

Chem Biol. 2000 Oct;7(10):793-803.

10.

Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.

Lee JH, Jung HS, Giang PM, Jin X, Lee S, Son PT, Lee D, Hong YS, Lee K, Lee JJ.

J Pharmacol Exp Ther. 2006 Jan;316(1):271-8. Epub 2005 Sep 23.

12.

The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia.

Holmes T, O'Brien TA, Knight R, Lindeman R, Symonds G, Dolnikov A.

Curr Med Chem. 2008;15(15):1493-9. Review.

PMID:
18537625
13.

Dual regulation of glycogen synthase kinase-3beta by the alpha1A-adrenergic receptor.

Ballou LM, Tian PY, Lin HY, Jiang YP, Lin RZ.

J Biol Chem. 2001 Nov 2;276(44):40910-6. Epub 2001 Aug 31.

14.

Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.

Tse AK, Wan CK, Shen XL, Yang M, Fong WF.

Biochem Pharmacol. 2005 Nov 15;70(10):1443-57. Epub 2005 Sep 21.

PMID:
16181613
16.

Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.

Steinbrecher KA, Wilson W 3rd, Cogswell PC, Baldwin AS.

Mol Cell Biol. 2005 Oct;25(19):8444-55.

17.

GSK-3beta negatively regulates skeletal myotube hypertrophy.

Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW.

Am J Physiol Cell Physiol. 2002 Aug;283(2):C545-51.

18.

Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.

Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, Fong WF.

Mol Immunol. 2007 Apr;44(10):2647-58. Epub 2007 Jan 22.

PMID:
17240450
19.
20.

Supplemental Content

Support Center